<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00825747</url>
  </required_header>
  <id_info>
    <org_study_id>SeeLensAF 65</org_study_id>
    <nct_id>NCT00825747</nct_id>
  </id_info>
  <brief_title>Evaluation of Seelens AF, an Aspheric Intra-Ocular Lens</brief_title>
  <official_title>Clinical Evaluation of the Aspheric SeeLens AF Intra-Ocular Lens.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hanita Lenses</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hanita Lenses</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Senile cataract is managed by cataract extraction and intra-ocular lens (IOL) implantation.
      The purpose of this study is to evaluate the safety and efficacy of the SeeLens AF, an
      acrylic hydrophilic aspheric IOL. This lens was designed to reduce vision aberrations and
      secondary cataract formation rate.

      Preoperative evaluation: Best corrected visual acuity, refraction, comprehensive slit lamp
      examination and biometry.

      Surgical procedure: Cataract surgery using a clear corneal incision (1.8mm to2.4mm),
      phacoemulsification and implantation of the SeeLens AF to the capsular bag. IOL implantation
      parameters will be evaluated by the surgeon.

      Postoperative follow up: Best corrected visual acuity, uncorrected visual acuity, refraction
      and comprehensive slit lamp examinations up to 3 months after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <primary_completion_date type="Anticipated">January 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best corrected visual acuity 3 months after SeeLens AF implantation</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications related to SeeLens AF implantation during cataract surgery.</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative severe intra-ocular inflammation or infection</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of ocular refraction after cataract surgery with Seelens AF implantation</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cataract</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SeeLens AF intra-ocular lens</intervention_name>
    <description>the SeeLens AF is an acrylic hydrophilic C shaped haptics intra-ocular lens, designed for implantation in the lenticular capsular bag or the sulcus during cataract surgery.</description>
    <other_name>aspheric SeeLens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Senile Cataract

          -  Age &gt;18 years

          -  Cataract extraction using phacoemulsification

          -  Corneal incision less than 1.5 mm

        Exclusion Criteria:

          -  Allergy/sensitivity to eye drops used during and after cataract surgery

          -  Amblyopia/ strabismus

          -  Ocular disease, other than cataract, diminishing visual acuity, such as corneal
             opacity, advanced glaucoma, diabetic retinopathy, exudative or moderate to severe
             non-exudative age-related macular degeneration, uveitis.

          -  previous ocular surgery or ocular trauma in the investigated eye

          -  Ocular anomaly, such as microphthalmos

          -  Keratometry values less than 40 diopters or more than 47 diopters.

          -  Ocular axial length less than 21.0 mm or longer than 25.0 mm

          -  Intra-operative complications prior to intraocular lens implantation, such as tear of
             the posterior capsule.

          -  posterior capsular scar

          -  visual acuity in the fellow eye less than 20/200
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yokrat Ton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center, affiliated with Tel-Aviv University, Tel-Aviv, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simha Siboni</last_name>
    <phone>972-52-3749535</phone>
    <email>simha@hanitalenses.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dorit Kelner</last_name>
    <phone>972-52-4239162</phone>
    <email>dorit@hanitalenses.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Beer Sheva</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Noam Yanculovich, MD</last_name>
      <phone>972-8-6400496</phone>
      <email>yanculov@bgu.ac.il</email>
    </contact>
    <investigator>
      <last_name>Noam Yanculovich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar-Saba</city>
        <zip>44410</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yokrat Ton, MD</last_name>
      <phone>972-9-7472154</phone>
      <email>barakton@013.net.il</email>
    </contact>
    <contact_backup>
      <last_name>Ehud I Assia, MD</last_name>
      <phone>972-9-7471527</phone>
      <email>assia@netvision.net.il</email>
    </contact_backup>
    <investigator>
      <last_name>Yokrat Ton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ehud Assia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fani Segev, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2009</study_first_submitted>
  <study_first_submitted_qc>January 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2009</study_first_posted>
  <last_update_submitted>January 20, 2009</last_update_submitted>
  <last_update_submitted_qc>January 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Simha Siboni, regulatory manager</name_title>
    <organization>Hanita Lenses, Israel</organization>
  </responsible_party>
  <keyword>Cataract</keyword>
  <keyword>Cataract surgery</keyword>
  <keyword>intraocular lens</keyword>
  <keyword>Aspheric lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

